David G. Menter

8.5k total citations · 1 hit paper
136 papers, 5.9k citations indexed

About

David G. Menter is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, David G. Menter has authored 136 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 44 papers in Cancer Research and 40 papers in Molecular Biology. Recurrent topics in David G. Menter's work include Colorectal Cancer Treatments and Studies (27 papers), Inflammatory mediators and NSAID effects (24 papers) and Cancer Genomics and Diagnostics (18 papers). David G. Menter is often cited by papers focused on Colorectal Cancer Treatments and Studies (27 papers), Inflammatory mediators and NSAID effects (24 papers) and Cancer Genomics and Diagnostics (18 papers). David G. Menter collaborates with scholars based in United States, Australia and Japan. David G. Menter's co-authors include Scott Kopetz, Anil K. Sood, Scott M. Lippman, Raymond N. DuBois, Kenneth V. Honn, Anita L. Sabichi, Vahid Afshar‐Kharghan, Garth L. Nicolson, Monika Haemmerle and Rebecca L. Stone and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

David G. Menter

134 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Platelet Lifeline to Cancer: Challenges and Opportunities

2018 462 citations David G. Menter, Vahid Afshar‐Kharghan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David G. Menter United States	43	2.6k	2.1k	1.4k	984	748	136	5.9k
John G. Kuhn United States	55	3.4k 1.3×	3.8k 1.8×	1.4k 1.0×	1.8k 1.8×	831 1.1×	188	8.8k
Joji Kitayama Japan	49	2.7k 1.0×	2.9k 1.4×	1.4k 1.0×	1.1k 1.1×	482 0.6×	195	7.4k
Massimo Broggini Italy	48	3.1k 1.2×	4.8k 2.3×	1.4k 1.0×	1.1k 1.2×	633 0.8×	236	7.6k
Steffen Hauptmann Germany	42	1.4k 0.5×	2.1k 1.0×	1.0k 0.7×	634 0.6×	339 0.5×	111	4.9k
Tetsuji Takayama Japan	37	1.7k 0.6×	2.3k 1.1×	774 0.5×	1.1k 1.1×	880 1.2×	268	6.2k
Gerald Höefler Austria	50	2.1k 0.8×	4.2k 2.0×	2.3k 1.6×	1.1k 1.1×	815 1.1×	192	9.3k
Masato Sakon Japan	54	2.8k 1.1×	3.4k 1.6×	1.6k 1.1×	1.6k 1.6×	882 1.2×	383	9.9k
Alfredo Budillon Italy	50	2.6k 1.0×	3.7k 1.8×	1.1k 0.8×	974 1.0×	364 0.5×	203	6.7k
Ying Yang China	41	1.7k 0.6×	2.2k 1.0×	1.3k 0.9×	868 0.9×	432 0.6×	136	5.1k
Claudio Festuccia Italy	45	1.6k 0.6×	2.8k 1.4×	1.1k 0.8×	1.1k 1.1×	313 0.4×	164	5.3k

Countries citing papers authored by David G. Menter

Since Specialization

Citations

This map shows the geographic impact of David G. Menter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Menter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Menter more than expected).

Fields of papers citing papers by David G. Menter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Menter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Menter. The network helps show where David G. Menter may publish in the future.

Co-authorship network of co-authors of David G. Menter

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Menter. A scholar is included among the top collaborators of David G. Menter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Menter. David G. Menter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Kangyu, Saikat Chowdhury, Mohammad A. Zeineddine, et al.. (2023). Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing. Molecular Cancer Research. 22(4). 337–346. 8 indexed citations

Li, Xubin, Gonghong Yan, Jacob H. Elnaggar, et al.. (2022). Precision Combination Therapies Based on Recurrent Oncogenic Coalterations. Cancer Discovery. 12(6). 1542–1559. 20 indexed citations

Sorokin, Alexey V., Preeti Kanikarla Marie, Ganiraju C. Manyam, et al.. (2022). Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Research. 82(18). 3335–3344. 37 indexed citations

Corvigno, Sara, Kwong‐Kwok Wong, Min Soon Cho, et al.. (2022). Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles. Molecular Cancer Therapeutics. 21(7). 1067–1075. 14 indexed citations

Marie, Preeti Kanikarla, Natalie W. Fowlkes, Vahid Afshar‐Kharghan, et al.. (2021). The Provocative Roles of Platelets in Liver Disease and Cancer. Frontiers in Oncology. 11. 643815–643815. 17 indexed citations

Adam, Liana, F. Anthony San Lucas, Richard Fowler, et al.. (2018). DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clinical Cancer Research. 25(2). 641–651. 19 indexed citations

Kim, Sun-Hee, Jason Roszik, Sung-Nam Cho, et al.. (2018). The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma. Clinical Cancer Research. 25(5). 1650–1663. 42 indexed citations

Parseghian, Christine M., Nila U. Parikh, Ji Yuan Wu, et al.. (2017). Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(15). 4146–4154. 47 indexed citations

Loree, Jonathan M., Allan Andresson Lima Pereira, Michael Lam, et al.. (2017). Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes. Clinical Cancer Research. 24(5). 1062–1072. 201 indexed citations

10.

Κατσιαμπούρα, Αναστασία, Kanwal Raghav, Zhi-Qin Jiang, et al.. (2017). Modeling of Patient-Derived Xenografts in Colorectal Cancer. Molecular Cancer Therapeutics. 16(7). 1435–1442. 38 indexed citations

11.

Lam, Michael, Jason Roszik, Preeti Kanikarla Marie, et al.. (2017). The potential role of platelets in the consensus molecular subtypes of colorectal cancer. Cancer and Metastasis Reviews. 36(2). 273–288. 34 indexed citations

12.

Menter, David G., Stephanie C. Tucker, Scott Kopetz, et al.. (2014). Platelets and cancer: a casual or causal relationship: revisited. Cancer and Metastasis Reviews. 33(1). 231–269. 238 indexed citations

13.

Holla, Vijaykumar, Thiruvengadam Arumugam, Rosa F. Hwang, et al.. (2012). Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor. Pancreas. 42(3). 467–474. 43 indexed citations

14.

Xia, Dianren, Vijaykumar Holla, Dingzhi Wang, David G. Menter, & Raymond N. DuBois. (2010). HEF1 Is a Crucial Mediator of the Proliferative Effects of Prostaglandin E2 on Colon Cancer Cells. Cancer Research. 70(2). 824–831. 22 indexed citations

15.

Asano, Takayuki, Yixin Yao, Ronghua Zhang, et al.. (2009). Activator Protein-1 Has an Essential Role in Pancreatic Cancer Cells and Is Regulated by a Novel Akt-Mediated Mechanism. Molecular Cancer Research. 7(5). 745–754. 21 indexed citations

16.

Yang, Peiying, David G. Menter, Carrie Cartwright, et al.. (2009). Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets. Molecular Cancer Therapeutics. 8(8). 2319–2328. 70 indexed citations

17.

Jin, Quanri, David G. Menter, Li Mao, Waun Ki Hong, & Ho‐Young Lee. (2008). Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure. Carcinogenesis. 29(8). 1614–1622. 42 indexed citations

18.

Kim, Jeri, Funda Vakar‐Lopez, Anita L. Sabichi, et al.. (2004). Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity. Journal of Biological Chemistry. 279(18). 19191–19200. 73 indexed citations

19.

Menter, David G., John L. Herrmann, Dario Marchetti, & Garth L. Nicolson. (1995). Involvement of neurotrophins and growth factors in brain metastasis formation.. PubMed. 14(1-6). 372–84. 38 indexed citations

20.

Menter, David G., et al.. (1987). Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.. PubMed. 7(2). 109–28. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact